Bioengineering and Medical Devices Unit
Develops and optimizes bioengineering platforms to produce new commercial products focused on the early detection and prevention of metabolic disorders associated with obesity.
What does this unit do?
1. Bioengineering of processes to identify and produce bioactives.
2. Development of medical devices for early detection and monitoring.
3. Engineering of delivery systems and detection of molecules.
4. Generation of clinical interventions that positively impact society.
Products and services developed by the unit
- Selection of novel biomolecules associated with metabolic diseases.
- Medical devices (based on new technologies, user-friendly and accessible) for the early detection and monitoring of metabolic diseases.
- Real-time detection sensors of biomarkers associated with metabolic diseases.
- Improvement of the performance of existing platforms for the early detection and monitoring of metabolic diseases.
- Prevention and treatment strategies for metabolic diseases and their complications.
- Strategies for the prediction and monitoring of risk of metabolic diseases.
Meet the researchers
Marco Antonio Rito Palomares
Unit leader. Full Research Professor
Development of early detection technologies, drug delivery systems and strategies based on aqueous two-phase systems.
Get to know his work
Jorge Alejandro Benavides Lozano
Associate Research Professor
Bioengineering, Bioprocesses, Bioproduct formulation, Bioactive discovery and characterization, Synthetic biology.
Get to know his work
Karla Patricia Mayolo Deloisa
Research Professor
Specialist in nanoparticle formulation, protein modification and bioprocesses.
Get to know her work
Omar Lozano García
Assistant Research Professor
Design of advanced materials for drug delivery systems and probes, preclinical studies, nanosafety, nano-bio-interactions.
Get to know his work
Alexandro José Martagón Rosado
Assistant Research Professor
Physician-researcher with translational focus in the study of metabolic diseases, such as obesity, type 2 diabetes and dyslipidemias.
Get to know his work
Mirna Alejandra González González
Assistant Research Professor
Development of flexible bioengineering platforms for biomedical applications.
Get to know her work
Latest Works and Publications of the Institute
- Rational selection of bioactive principles for wound healing applications: Growth factors and antioxidants. International Wound Journal. 19:100-113. 2022
- A systematic review of post-translational modifications in the mitochondrial permeability transition pore complex associated with cardiac diseases. Biochimica et Biophysica Acta - Molecular Basis of Disease. 1867. 2021
- Cardiotoxicity associated with immune checkpoint inhibitor therapy: a meta-analysis. European Journal of Heart Failure. 23:1739-1747. 2021
- Current challenges and future trends of enzymatic paper-based point-of-care testing for diabetes mellitus type 2. Biosensors. 11. 2021
- Development of aqueous two-phase systems-based approaches for the selective recovery of metalloproteases and phospholipases A2 toxins from Crotalus molossus nigrescens venom. Bioresources and Bioprocessing. 8. 2021
- Enzymatic methods for salivary biomarkers detection: Overview and current challenges. Molecules. 26. 2021
- Evaluation of the immune response of a candidate phage-based vaccine against Rhipicephalus microplus (Cattle tick). Pharmaceutics. 13. 2021
- Familial hypertriglyceridemia: an entity with distinguishable features from other causes of hypertriglyceridemia. Lipids in Health and Disease. 20. 2021
- LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred. Lipids in Health and Disease. 20. 2021
- Non-thermal technologies as tools to increase the content of health-promoting compounds in whole fruits and vegetables while retaining quality attributes. Foods. 10. 2021